Canada Markets open in 7 hrs 4 mins

Catalyst Biosciences, Inc. (CBIO)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.0900-0.0400 (-3.54%)
At close: 04:00PM EST
Full screen
Trade prices are not sourced from all markets
Previous Close1.1300
Open1.1200
Bid1.0800 x 2200
Ask1.0900 x 2900
Day's Range1.0707 - 1.1401
52 Week Range1.0700 - 7.5500
Volume658,758
Avg. Volume619,012
Market Cap34.171M
Beta (5Y Monthly)1.77
PE Ratio (TTM)N/A
EPS (TTM)-3.2980
Earnings DateAug. 04, 2021 - Aug. 09, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateAug. 20, 2015
1y Target Est16.60
  • GlobeNewswire

    Catalyst Biosciences to Present at the Piper Sandler 33rd Annual Virtual Healthcare Conference

    SOUTH SAN FRANCISCO, Calif., Nov. 22, 2021 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO) today announced that members of its executive management team will participate in a fireside chat at the Piper Sandler 33rd Annual Virtual Healthcare Conference, being held November 29-December 2, 2021. The fireside chat will be available on-demand for registered attendees via the Piper Sandler conference site beginning Monday, November 22, 2021 at 10:00 am ET until the end of the conference

  • GlobeNewswire

    Catalyst Biosciences Announces Change in Corporate Strategy

    Reports Third Quarter 2021 Operating & Financial ResultsCompany to discontinue MarzAA development; focus on developing its complement portfolio Management to host a call today at 8:30 am ET SOUTH SAN FRANCISCO, Calif., Nov. 12, 2021 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO) today announced a strategic decision to halt the clinical development of MarzAA, report data to date, and seek a buyer for its hemophilia assets. Catalyst plans to focus its resources on its complement the